{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:37:31Z","timestamp":1740119851597,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670680","81300623","81700655"],"award-info":[{"award-number":["81670680","81300623","81700655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030313135","2014A030313022"],"award-info":[{"award-number":["2015A030313135","2014A030313022"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.transproceed.2018.03.043","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T11:33:33Z","timestamp":1521372813000},"page":"2382-2387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Early Immunosuppression Therapy on De Novo Anti\u2013Human-Leukocyte-Antigen Antibody After Kidney Transplantation"],"prefix":"10.1016","volume":"50","author":[{"given":"H.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.03.043_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients[J]","volume":"100","author":"O'Leary","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.043_bib2","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1600-6143.2006.01711.x","article-title":"Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study","volume":"7","author":"Mao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.043_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000170843","article-title":"Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications","volume":"162","author":"Briggs","year":"2009","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib6","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/TP.0000000000000672","article-title":"Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing","volume":"99","author":"Susal","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.043_bib7","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1432-2277.2005.00085.x","article-title":"Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation","volume":"18","author":"Cardarelli","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.03.043_bib9","first-page":"171","article-title":"Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up","author":"Lachmann","year":"2006","journal-title":"Clin Transpl"},{"issue":"Suppl. 185","key":"10.1016\/j.transproceed.2018.03.043_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ijcp.12813","article-title":"The efficacy and safety of intensified enteric-coated mycophenolate sodium with low exposure of calcineurin inhibitors in Chinese de novo kidney transplant recipients: a prospective study","volume":"70","author":"Zhang","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.transproceed.2018.03.043_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.TP.0000438636.52085.50","article-title":"Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents","volume":"97","author":"Shin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.043_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/petr.12637","article-title":"Minimum mycophenolic acid levels are associated with donor-specific antibody formation","volume":"20","author":"Filler","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib13","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/tid.12467","article-title":"Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction","volume":"17","author":"Dieplinger","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2018.03.043_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/TP.0b013e3181c3503e","article-title":"Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection","volume":"89","author":"Gill","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.03.043_bib15","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/ajt.13795","article-title":"Impact of early blood transfusion after kidney transplantation on the incidence of donor-specific anti-HLA antibodies","volume":"16","author":"Ferrandiz","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2018.03.043_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib19","first-page":"143","article-title":"Pre-transplantation anti-HLA antibody screening in kidney allograft recipients (3500 cases)","volume":"25","author":"Fu","year":"2009","journal-title":"Chinese J Immunol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/13.1.160","article-title":"Suppression of the humoral immune response by mycophenolate mofetil","volume":"13","author":"Smith","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/j.transproceed.2018.03.043_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2002.00425.x","article-title":"Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in\u00a0vivo","volume":"62","author":"Rentenaar","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.043_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2010.269","article-title":"Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses","volume":"78","author":"Struijk","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2018.03.043_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0012.2005.00261.x","article-title":"Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation","volume":"19","author":"Lederer","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5414\/CN107908","article-title":"A\u00a0randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year","volume":"79","author":"Arns","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ijcp.12403","article-title":"A\u00a0single-centre, open-label, prospective study of an initially short-term intensified dosing regimen of enteric-coated mycophenolate sodium with reduced cyclosporine A exposure in Chinese live-donor kidney transplant recipients","author":"Cai","year":"2014","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.transproceed.2018.03.043_bib29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2215\/CJN.09091209","article-title":"The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation","volume":"5","author":"Gourishankar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.03.043_bib30","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib31","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.03.043_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.humimm.2009.04.013","article-title":"Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report","volume":"70","author":"Susal","year":"2009","journal-title":"Hum Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518303762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:22:51Z","timestamp":1539220971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518303762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0041134518303762"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.043","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Early Immunosuppression Therapy on De Novo Anti\u2013Human-Leukocyte-Antigen Antibody After Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}